当前位置:首页 - 行情中心 - 智飞生物(300122) - 财务分析

智飞生物

(300122)

  

流通市值:214.27亿  总市值:362.66亿
流通股本:14.14亿   总股本:23.94亿

智飞生物(300122)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-3.94亿元,每股收益-0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益1571242.92万元,未分配利润1195359.79万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产2909203.93万元,负债1337961.01万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入2,150,185,419.458,958,435,384.967,644,356,433.974,925,196,928.5
营业总成本2,218,602,295.9612,358,235,775.898,826,798,368.985,355,146,772
其他经营收益
营业利润-441,995,299.04-17,459,994,187.58-1,655,892,354.87-785,270,344.63
利润总额-444,905,658.67-17,492,662,390.75-1,657,117,691.54-786,333,985.55
净利润-393,703,391.88-14,745,264,578.46-1,340,955,074.7-598,076,899.29
每股收益
其他综合收益----
综合收益总额-393,703,391.88-14,745,264,578.46-1,340,955,074.7-598,076,899.29
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计16,417,783,333.4219,019,102,11336,113,056,421.7837,177,490,667.69
非流动资产:
非流动资产合计12,674,255,942.8912,700,615,190.1310,302,895,862.968,792,169,863.37
资产总计29,092,039,276.3131,719,717,303.1346,415,952,284.7445,969,660,531.06
流动负债:
流动负债合计5,227,544,96412,403,766,355.3113,004,471,297.4515,177,952,392.85
非流动负债:
非流动负债合计8,152,065,145.213,209,818,388.853,901,038,924.56533,827,628.58
负债合计13,379,610,109.2115,613,584,744.1616,905,510,222.0115,711,780,021.43
所有者权益(或股东权益):
归属于母公司股东权益合计15,451,462,539.5315,839,778,818.5329,235,038,558.1330,257,880,509.63
股东权益合计15,712,429,167.116,106,132,558.9729,510,442,062.7330,257,880,509.63
负债和股东权益合计29,092,039,276.3131,719,717,303.1346,415,952,284.7445,969,660,531.06
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计2,158,084,818.615,029,525,457.9511,125,790,912.47,548,643,715.42
经营活动现金流出小计1,880,015,523.799,862,205,774.268,140,772,017.835,984,269,026.93
经营活动产生的现金流量净额278,069,294.815,167,319,683.692,985,018,894.571,564,374,688.49
投资活动产生的现金流量:
投资活动现金流入小计20,00089,245,175.8287,773,459.9110,817,645.6
投资活动现金流出小计102,111,213.21684,186,865.2527,338,343.65259,397,490.09
投资活动产生的现金流量净额-102,091,213.21-594,941,689.38-439,564,883.74-248,579,844.49
筹资活动产生的现金流量:
筹资活动现金流入小计7,985,717,17613,353,450,918.5413,003,450,918.547,724,634,474.26
筹资活动现金流出小计9,060,967,876.2818,086,250,936.7315,757,747,983.529,174,961,023.49
筹资活动产生的现金流量净额-1,075,250,700.28-4,732,800,018.19-2,754,297,064.98-1,450,326,549.23
汇率变动对现金及现金等价物的影响-16,911,711.49-687,237.77-407,575.19-443,332.42
现金及现金等价物净增加额-916,184,330.17-161,109,261.65-209,250,629.34-134,975,037.65
期末现金及现金等价物余额1,626,775,775.142,542,960,105.312,494,818,737.622,563,881,364.33
补充资料:
现金及现金等价物的净增加额--161,109,261.65--134,975,037.65
TOP↑